“Bayer has been working to improve women’s health in Australia for more than 60 years, and with the PBS listing of YAZ and YASMIN, we are proud to demonstrate this commitment to advancing women’s health by providing solutions for her different reproductive needs," said Manoj Saxena, CEO of Bayer Australia and New Zealand and country division head for the pharmaceutical division …
A 'milestone moment' with first oral contraceptive listed on the PBS in over 30 years
March 2, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
PYC to present early polycystic kidney disease trial data at US nephrology conference
October 7, 2026 - - Australian Biotech -
CSL raises US$1.5 billion from US bond investors to refinance debt
October 7, 2026 - - Latest News -
Every serious attempt to reform PBS pricing has run into the same problem
October 7, 2026 - - Latest News -
AFT reaffirms profit guidance as its R&D pipeline moves toward 2029 launches
October 7, 2026 - - Latest News -
The patient who knows what they want is informed and not a danger
October 7, 2026 - - Latest News -
TGA turns to national security surveillance platform to police therapeutic goods compliance
October 6, 2026 - - Latest News -
Company size shapes CEO pay trends in Australian health care and biotechnology
October 6, 2026 - - Latest News